1 / 24

Alcohol and the Liver

Alcohol and the Liver. A Case Study. Leslie Anderson. Patient Background. SH was 42 y.o . Caucasian male, married with 2 children Smoked half a pack a day, drank a fifth of whiskey daily Admitted to LDSH for alcohol detox – 08/11 Family History significant for Polycystic Kidney Disease.

ganya
Télécharger la présentation

Alcohol and the Liver

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Alcohol and the Liver A Case Study Leslie Anderson

  2. Patient Background • SH was 42 y.o. Caucasian male, married with 2 children • Smoked half a pack a day, drank a fifth of whiskey daily • Admitted to LDSH for alcohol detox – 08/11 • Family History significant for Polycystic Kidney Disease

  3. Past Medical History • Hypertension • Dyslipidemia • Polycystic kidney disease (recent diagnosis) • Lymph node resection • Alcohol abuse with previous evidence of alcoholic hepatitis

  4. Hospital Events/Procedures • 11/2: SH admitted to ER • 11/3: Transferred to ICU; Intubated d/t respiratory distress • Plan to admit to psychiatric unit to assist in his alcohol detoxification

  5. Alcohol and the Liver • The liver detoxifies 90% of ingested alcohol • Metabolism of alcohol is the main cause of liver damage • Alcoholic Liver Disease (ALD) is the cause of 50% of all liver disease cases • SteatosisSteatohepatitis Cirrhosis

  6. Risk Factors • Binge/Chronic Drinking • Drinking between meals • Type of beverage • Family history of disease • Females > Males

  7. Metabolism of Alcohol • Alcohol Dehydrogenase (ALD) • Metabolizes 80% of ingested alcohol • Ethanol AcetaldehydeAcetateAcetyl-CoACo2 +H2O • Leads to hepatic steatosis • Cytochrome P450 2E1 (CYP2E1) • Previously called inducible microsomal ethanol-oxidizing system (MEOS) • Used most in chronic alcoholism • Catalase enzyme • Non-oxidative process • Leads to hepatic steatosis

  8. Toxic Effect of Alcohol • Ethanol • “Leaky gut” • Reactive Oxygen Species (ROS) • Compromised immunity • Acetaldehyde – Key toxin • Cellular damage, inflammation, extracellular matrix remodeling and fibrinogenesis • Acetate/Acetyl Co-A • Increased IL-6, IL-8, TNF-a • Effects perpetuate and progress

  9. Nutritional Concerns • Malnutrition • Alcohol substitution • Malabsorption • Altered macronutrient metabolism • Reduced glucose production, often accompanied by insulin resistance • Lipids are malabsorbed and remain in circulation d/t decreased bile secretion • Increased protein catabolism with inadequate resynthesis

  10. Vitamin/Mineral Deficiences • Decreased: • Intake of nutritious foods • Absorption • Storage • Increased Use: • Antioxidants • Metabolism of alcohol

  11. Proposed Supplements • Milk Thistle (Silymaryin) • Safe, well-tolerated • No benefit noted • S-Adenyosylmethionine • Precursor to glutathione (antioxidant) • No benefit seen • Metadoxine • Not approved in U.S. • Decreased lipid accumulation • Phosphatidylcholine • Fibrosis-reducing effect • More studies needed

  12. Anthropometrics • Wt: 106.3 kg • Ht: 182.9 cm • IBW: 80.8 kg • % IBW:132 • BMI: 31.78 • Adj BW: 90.5 kg

  13. Estimated Nutrition Needs • 2100-2550 kcals (23-28 kcal/kg) • 80-95 g protein (1.0-1.2 g/kg) • 2800 ml fluid (35 ml/kg) • Adjusted wt used for energy needs • IBW used for protein and fluid needs

  14. Biochemical Data

  15. Biochemical Data, continued

  16. Clinical Data • Febrile – 38.9º C • Tremors – r/t alcohol detoxification • Questionable ascites • Unable to determine d/t body habitus

  17. Medications • Anesthesia/Sedative • Propofol – (85 kcal/day) • Antianxiety • AntiGERD • Antiemetic • Fluid/Electrolyte/Vitamin replacement

  18. Diet Order

  19. Nutrition Assessment • Pt at high nutrition risk r/t inability to take PO, confusion, and intubation. BMI 31.8 indicates obesity. Albumin was wnl upon admit, with lowered labs d/t fluid administration. Altered labs r/t liver disease precipitated by alcohol consumption. Will continue to monitor lipase to determine possibility of PO intake vs. need for NJ past ligament of Trietz upon NPO day 2. Decreased estimated energy requirements d/t intubation. Unable to talk to pt at this time.

  20. Nutrition Problem & Goals • Excessive alcohol intake r/t alcohol or drug addiction AEB elevated alcohol, LFT’s, and lipase lab values. • Advance diet as tolerated and as medically able.

  21. Interventions • MVI, thiamin, folic acid • NPO d/t elevated lipase

  22. Recommendations • If still NPO by tomorrow, recommend initiation of enteral feeds past the ligament of Trietz. Initiate feeds of Peptamen AF @ 20 ml/hr and monitor labs for refeeding syndrome as Phos is already low. End goal rate for pt is Peptamen AF @ 75 ml/hr = 24 kcal/kg Adj wt and 1.7 g prot/kg.

  23. Prognosis • Poor d/t: • PKD • Alcoholic Hepatitis • continued alcohol abuse • Need for continued medical care • Possible dialysis • Possible transplants

  24. References • Hasse JM, Matarese LE. Medical nutrition therapy for liver, biliary system, and exocrine pancreas disorders. In: Mahan LK, Escott-Stump S, ed. Krause’s Food & Nutrition Therapy. 12 ed. St. Louise, MO: Saunders Elsevier; 2008:707-727. • The Merck Manual of Diagnosis and Therapy. 18th  ed.  Whitehouse Station, NJ; 2006:1129-1131. • Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J GastroenterolHepatol. 2011:26;1089-1105. • Szabo G, Mandrekar P. Focus on: Alcohol and the liver. Alcohol Res Health. 2010:33;87-96. • Griffith CM, Schenker S. The role of nutritional therapy in alcoholic liver disease. Alcohol Res Health. 2006:29(4):296-306.

More Related